Trial Profile
The Impact of LY2605541 versus Insulin Glargine for Patients with Type 1 Diabetes Mellitus Treated with Preprandial Insulin Lispro: an Open-Label, Randomized, 78 week study - The IMAGINE 1 Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Jan 2023
Price :
$35
*
At a glance
- Drugs Insulin peglispro (Primary) ; Insulin glargine; Insulin lispro
- Indications Type 1 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms IMAGINE-1
- Sponsors Eli Lilly and Company
- 09 Jun 2015 Results (pooled analysis of IMAGINE 1, 2, 3, 4, 5 and 6 trials) presented at the 75th Annual Scientific Sessions of the American Diabetes Association.
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.
- 06 Jun 2015 Results published in an Eli Lilly media release.